Pharmaceuticals

Pharmaceuticals Native Starch Market Size and Growth Forecast for Businesses 2025–2029

November 10, 2025 by Marketing Posting

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

#What Are The Current (2025) And Forecast (2029) Sizes Of The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market size has experienced significant expansion over recent years. It is anticipated to increase from $5.65 billion in 2024 to $6.11 billion in 2025, driven by a compound annual growth rate (CAGR) of 8.1%. This growth during the past period is primarily due to the heightened demand for natural excipients, increasing pharmaceutical output, a growing preference for biocompatible ingredients, the expansion of generic drug manufacturing, and rising regulatory encouragement for natural ingredients.

The pharmaceuticals native starch market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach $8.5 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 8.6%. Key factors driving this growth during the forecast period include increasing investment in pharmaceutical innovation, an amplified focus on sustainable sourcing, expanding applications within novel drug formulations, a heightened demand for clean-label pharmaceutical products, and growing healthcare expenditure in emerging markets. Significant trends observed during this period encompass technological advancements in starch processing, innovations within drug delivery systems, new developments in bio-based pharmaceutical ingredients, extensive research and development in plant-based excipients, and the creation of solubility and stability solutions.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24376&type=smp

What Are The Emerging Market Drivers Creating New Opportunities In The Pharmaceuticals Native Starch Industry?

The rising incidence of chronic ailments is anticipated to drive expansion in the pharmaceuticals native starch market moving ahead. These conditions are enduring health issues, generally characterized by a gradual progression and a duration of at least one year. The heightened occurrence of chronic diseases stems largely from the growing elderly demographic, given that older people are more prone to prolonged health problems like diabetes, cardiovascular diseases, arthritis, and cancer, which typically become more widespread as people age. Pharmaceuticals native starch proves beneficial in the context of chronic diseases by enhancing drug formulation stability, boosting bioavailability, facilitating regulated drug release, aiding patient adherence, and ultimately reinforcing the efficacy and sustained management of these medical conditions. As an illustration, data from June 2024, provided by the Australian Institute of Health and Welfare, an Australia-based government agency, indicated an increase in the mortality rate from chronic conditions, moving from 459 per 100,000 people in 2021 to 490 per 100,000 people in 2022. Consequently, the rising occurrence of chronic illnesses is propelling the expansion of the pharmaceuticals native starch market.

What Are The Key Segments In The Pharmaceuticals Native Starch Market?

The pharmaceuticals native starch market covered in this report is segmented –

1) By Type: Potato Starch, Corn Starch, Other Types

2) By Formulation Type: Oral Solid Dosage Forms, Liquid Dosage Forms, Topical Formulations, Injectable Drugs, Controlled Release Formulations

3) By Functionality: Texturizing Agent, Moisture Retention Agent, Bulking Agent, Emulsifying Agent, Film-Forming Agent

4) By Application: Binders And Coating Agents, Disintegrants, Fillers And Extenders, Stabilizers, Thickening Agents

5) By End-User: Pharmaceutical Manufacturers, Contract Research Organizations (CROs), Contract Manufacturing Organizations (CMOs), Research And Development Labs, Academic Institutions, Other End-users

Subsegments:

1) By Potato Starch: Modified Potato Starch, Native Potato Starch

2) By Corn Starch: Modified Corn Starch, Native Corn Starch

3) By Other Types: Rice Starch, Wheat Starch, Tapioca Starch

Which Ongoing Trends Are Expected To Shape The Pharmaceuticals Native Starch Market Outlook?

Leading companies in the pharmaceuticals native starch market are concentrating on developing innovative products, such as plant-based textures, to enhance drug formulation and improve patient compliance. Plant-based texture refers to the physical characteristics derived from botanical ingredients, including thickness and gel strength, and assists pharmaceuticals in using native starch by improving tablet binding, disintegration, and mouthfeel for better natural drug formulations. For instance, in February 2024, Ingredion Incorporated, a US-based food company, launched Novation Indulge 2940 starch, a clean-label texturizer designed to improve texture and stability in dairy and alternative dairy products. This advanced pharmaceutical native starch offers functional properties that boost drug formulation performance, bioavailability, and controlled release, while also supporting the creation of clean-label, sustainable products. NOVATION Indulge 2940 starch is a versatile ingredient that enhances texture, stability, and consumer acceptance in both dairy and alternative dairy products, utilizing clean-label, natural ingredients.

Who Are The Major Companies Operating In The Pharmaceuticals Native Starch Market?

Major companies operating in the pharmaceuticals native starch market are Cargill Incorporated, Archer Daniels Midland Company, Ingredion Incorporated, Tereos SCA, Roquette Frères SA., AGRANA, Tate & Lyle Public Limited Company, Colorcon Inc., Grain Processing Corporation, Siam Modified Starch Co. Ltd., BENEO GmbH, Gulshan Polyols Ltd., SPAC Starch Products (India) Private Limited, Universal Starch-Chem Allied Ltd., Sanstar Biopolymers Ltd., Emsland Group, Hungrana Kft., Bluecraft Agro Pvt. Ltd., Visco Starch, Shandong Liujia Pharmaceutical Excipient Co.Ltd.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-native-starch-global-market-report

What Are The Key Regional Factors Influencing The Pharmaceuticals Native Starch Market Growth?

North America was the largest region in the pharmaceuticals native starch market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceuticals native starch market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Version Of The Pharmaceuticals Native Starch Market Report:

https://www.thebusinessresearchcompany.com/customise?id=24376&type=smp

Browse Through More Reports Similar to the Global Pharmaceuticals Native Starch Market 2025, By The Business Research Company

Generic Pharmaceuticals Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/generic-pharmaceuticals-global-market-report

Pharmaceuticals Market 2025

https://www.thebusinessresearchcompany.com/report/pharmaceuticals-market

Radiopharmaceutical Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/radiopharmaceutical-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795